DE60235088D1 - Dna-arrays zur messung der empfindlichkeit gegenüber einem antikrebsmittel - Google Patents

Dna-arrays zur messung der empfindlichkeit gegenüber einem antikrebsmittel

Info

Publication number
DE60235088D1
DE60235088D1 DE60235088T DE60235088T DE60235088D1 DE 60235088 D1 DE60235088 D1 DE 60235088D1 DE 60235088 T DE60235088 T DE 60235088T DE 60235088 T DE60235088 T DE 60235088T DE 60235088 D1 DE60235088 D1 DE 60235088D1
Authority
DE
Germany
Prior art keywords
anticancer agent
fragments
genes
gene
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60235088T
Other languages
English (en)
Inventor
Teiji Takechi
Katsuhisa Koizumi
Atsushi Azuma
Masakazu Fukushima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60235088D1 publication Critical patent/DE60235088D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60235088T 2001-07-05 2002-07-03 Dna-arrays zur messung der empfindlichkeit gegenüber einem antikrebsmittel Expired - Lifetime DE60235088D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001204448 2001-07-05
JP2001239181 2001-08-07
PCT/JP2002/006754 WO2003004640A1 (fr) 2001-07-05 2002-07-03 Reseaux d'adn permettant de mesurer la sensibilite a un agent anticancereux

Publications (1)

Publication Number Publication Date
DE60235088D1 true DE60235088D1 (de) 2010-03-04

Family

ID=26618186

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60235088T Expired - Lifetime DE60235088D1 (de) 2001-07-05 2002-07-03 Dna-arrays zur messung der empfindlichkeit gegenüber einem antikrebsmittel

Country Status (6)

Country Link
US (1) US20040265813A1 (de)
EP (1) EP1411120B1 (de)
JP (1) JPWO2003004640A1 (de)
AT (1) ATE455187T1 (de)
DE (1) DE60235088D1 (de)
WO (1) WO2003004640A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003006676A2 (en) 2001-07-13 2003-01-23 Nanosphere, Inc. Method for immobilizing molecules onto surfaces
CA2494262A1 (en) * 2002-07-31 2004-02-05 University Of Southern California Polymorphisms for predicting disease and treatment outcome
CN101357134A (zh) * 2003-03-14 2009-02-04 大鹏药品工业株式会社 抗肿瘤效果增强剂和抗肿瘤剂
US20070105114A1 (en) * 2003-07-29 2007-05-10 Martha Li Biomarkers of cyclin-dependent kinase modulation
JP2006042802A (ja) * 2004-06-28 2006-02-16 Sumitomo Chemical Co Ltd コモンマーモセット由来のヒポキサンチングアニンホスホリボシルトランスフェラーゼ遺伝子及びその利用
US20060115827A1 (en) * 2004-07-01 2006-06-01 University Of Southern California Genetic markers for predicting disease and treatment outcome
JP4956423B2 (ja) * 2005-04-01 2012-06-20 大鵬薬品工業株式会社 放射線治療増強剤
AU2006231809B2 (en) * 2005-04-01 2011-08-25 Taiho Pharmaceutical Co., Ltd. Potentiator for radiation therapy comprising pyridine derivative as active ingredient
WO2006132982A2 (en) * 2005-06-03 2006-12-14 Aviaradx, Inc. Normalization genes
US8768629B2 (en) 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
IL282783B2 (en) * 2006-05-18 2023-09-01 Caris Mpi Inc A system and method for determining a personalized medical intervention for a disease stage
JP5413818B2 (ja) * 2007-03-29 2014-02-12 国立大学法人佐賀大学 蛍光多重染色による蛋白定量法
EP3075864A1 (de) * 2008-10-14 2016-10-05 Caris MPI, Inc. Gen und genexprimierte zielproteine zur darstellung von biomarkermustern und signatursets nach tumortyp
EP3722810A3 (de) * 2009-02-11 2021-01-13 Caris MPI, Inc. Molekulare profilierung von tumoren
NZ593272A (en) * 2011-06-07 2013-02-22 Scott Pearson Breathing pipe with compartment having moutpiece and fan drivingly connected to a fan in another separated compartment to force air with active substance to outlet, typically near users nose to avoid nuisance to others
WO2016121715A1 (ja) * 2015-01-26 2016-08-04 国立大学法人名古屋大学 肺がん患者の予後を評価するための情報を提供する方法、肺がん患者の予後予測方法、内部標準、抗体、肺がん患者の予後予測装置、予後予測装置のプログラム及び記録媒体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
US6025194A (en) * 1997-11-19 2000-02-15 Geron Corporation Nucleic acid sequence of senescence asssociated gene
US9534254B1 (en) * 1999-02-02 2017-01-03 Abbott Molecular Inc. Patient stratification for cancer therapy based on genomic DNA microarray analysis
AU1466001A (en) * 1999-11-05 2001-05-14 Phase-1 Molecular Toxicology Methods of determining individual hypersensitivity to an agent

Also Published As

Publication number Publication date
JPWO2003004640A1 (ja) 2004-10-28
EP1411120A1 (de) 2004-04-21
US20040265813A1 (en) 2004-12-30
EP1411120B1 (de) 2010-01-13
ATE455187T1 (de) 2010-01-15
WO2003004640A1 (fr) 2003-01-16
EP1411120A4 (de) 2006-09-06

Similar Documents

Publication Publication Date Title
Chen et al. Alternative polyadenylation: methods, findings, and impacts
Radonić et al. Guideline to reference gene selection for quantitative real-time PCR
DE60235088D1 (de) Dna-arrays zur messung der empfindlichkeit gegenüber einem antikrebsmittel
CN101827941B (zh) 用于区分胰腺癌与正常胰腺功能和/或慢性胰腺炎的方法
JP2019526257A5 (de)
JP5769952B2 (ja) Ｅｍｌ４−ａｌｋ融合遺伝子の高感度検出方法
US20150299796A1 (en) Prediction of treatment response to jak/stat inhibitor
CN108949992B (zh) 一种与食管鳞癌及其分级相关的生物标志物
CN108277283A (zh) lncRNA组合在制备预测肾透明细胞癌预后及分子靶向药物治疗敏感性的产品中的应用
CA3077746A1 (en) Biomarkers useful for detection of types, grades and stages of human breast cancer
Wong et al. Identification of novel microRNAs in the sheep heart and their regulation in heart failure
CN104937112A (zh) 对WT1 mRNA的表达量进行定量的方法
KR102202726B1 (ko) 편평상피세포암의 진단 또는 예후 예측용 마커 및 이의 용도
Villaseñor-Park et al. Microarray technique, analysis, and applications in dermatology
Liu et al. Analysis of DNA hypermethylation in pancreatic cancer using methylation-specific PCR and bisulfite sequencing
CN109022583A (zh) hsa_circ_0021977在制备诊断乳腺癌产品上的应用
WO2001092538A1 (fr) Technique de detection et de quantification de l'espece moleculaire humaine p450, sonde et necessaire a cet effet
EP3321377B1 (de) Verfahren zur bestimmung der empfindlichkeit auf simultanen inhibitor gegen parp und tankyrase
CN107312851A (zh) 心肌梗死生物标志物miR‑1283
CN107058579A (zh) 肺腺癌相关的miRNA、组合物及其应用
CN110029153A (zh) 核酸多肽复合物探针及其制备方法和应用
CN109652529A (zh) 骨质疏松特异性miRNA、组合物及其诊疗用途
RU2451937C2 (ru) Способ диагностики рака молочной железы по уровню рнк интерлейкинов il-8 и/или il-18 в плазме крови
CN109439738A (zh) Abcb1、cyp3a5基因检测引物组、试剂盒及检测方法
CN105603069A (zh) 一种Bim基因缺失荧光定量PCR检测引物及探针、检测试剂盒

Legal Events

Date Code Title Description
8364 No opposition during term of opposition